Literature DB >> 17108344

Clinical practice. Acute bronchitis.

Richard P Wenzel1, Alpha A Fowler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17108344     DOI： 10.1056/NEJMcp061493

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  26 in total

Review 1.  Tobacco Worker's Lung: A Neglected Subtype of Hypersensitivity Pneumonitis.

Authors:  Vincenzo Zagà; Marco Dell'Omo; Nicola Murgia; Marco Mura
Journal:  Lung       Date:  2021-01-11       Impact factor: 2.584

Review 2.  Infection-related asthma.

Authors:  Jared I Darveaux; Robert F Lemanske
Journal:  J Allergy Clin Immunol Pract       Date:  2014-11-06

3.  Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections.

Authors:  Carmen L Charlton; Esther Babady; Christine C Ginocchio; Todd F Hatchette; Robert C Jerris; Yan Li; Mike Loeffelholz; Yvette S McCarter; Melissa B Miller; Susan Novak-Weekley; Audrey N Schuetz; Yi-Wei Tang; Ray Widen; Steven J Drews
Journal:  Clin Microbiol Rev       Date:  2018-12-12       Impact factor: 26.132

4.  Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia.

Authors:  David T Huang; Lisa A Weissfeld; John A Kellum; Donald M Yealy; Lan Kong; Michael Martino; Derek C Angus
Journal:  Ann Emerg Med       Date:  2008-03-17       Impact factor: 5.721

5.  Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance.

Authors:  F Dusemund; B Bucher; S Meyer; R Thomann; F Kühn; S Bassetti; M Sprenger; E Baechli; T Sigrist; M Schwietert; D Amin; P Hausfater; E Carre; P Schuetz; J Gaillat; K Regez; R Bossart; U Schild; B Müller; W C Albrich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-12       Impact factor: 3.267

6.  How do community practitioners decide whether to prescribe antibiotics for acute respiratory tract infections?

Authors:  Robert S Wigton; Carol A Darr; Kitty K Corbett; Devin R Nickol; Ralph Gonzales
Journal:  J Gen Intern Med       Date:  2008-07-12       Impact factor: 5.128

7.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

8.  Targeted Drug Delivery to Upper Airways Using a Pulsed Aerosol Bolus and Inhaled Volume Tracking Method.

Authors:  Yan Ostrovski; Simon Dorfman; Maksim Mezhericher; Stavros Kassinos; Josué Sznitman
Journal:  Flow Turbul Combust       Date:  2018-05-02       Impact factor: 2.305

9.  Effectiveness of anti-inflammatory treatment versus antibiotic therapy and placebo for patients with non-complicated acute bronchitis with purulent sputum. The BAAP Study protocol.

Authors:  Carl Llor; Ana Moragas; Carolina Bayona; Rosa Morros; Helena Pera; Josep M Cots; Yvonne Fernández; Marc Miravitlles; Albert Boada
Journal:  BMC Pulm Med       Date:  2011-06-21       Impact factor: 3.317

10.  Concurrent acute illness and comorbid conditions poorly predict antibiotic use in upper respiratory tract infections: a cross-sectional analysis.

Authors:  Ilene H Zuckerman; Eli N Perencevich; Anthony D Harris
Journal:  BMC Infect Dis       Date:  2007-05-30       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.